A Webinar with Miles G.Cunningham and Dr. Michael J. Cameron
CEUs: 2 (Type 2) CEUs for Board Certified Behavior Analyst
Fee: $25.00

Applied neuroscientific knowledge is central to understanding the brain’s influence over human behavior and learning. In consequence, Board Certified Behavior Analysts (BCBAs) can benefit from understanding the neurological variables that frequently impact the children, adolescents, and adults they serve. Chief among the influencing variables are: (a) pharmacologic agents and polypharmacological regimens for behavior control, (b) impairments in the brain reward circuitry, and (c) neurological damage. This webinar was designed in an effort to conceptually integrate and relate neuroscience and behavior to account for the complexity of behavior frequently observed in the clinics, centers, schools, hospitals, and home-based settings that BCBAs deliver services. Doctors Miles G. Cunningham and Michael J. Cameron will trace the early thinking of B.F. Skinner (Behavior of Organisms) to contemporary frames for relating behavior and neuroscience (e.g., J. Moore and John Donahoe) within this informative webinar.

Learning Objectives:
Following webinar participation, individuals will:

  1. Pinpoint behavioral scientists from the behavior analytic community that have contributed
    to the professional literature and have described the interface between behavior science and euroscience (e.g., J. Moore and J. Donahoe).
  2. Explain the implications for mirror neurons and how knowledge of mirror neurons can inform behavioral education practices (e.g., especially centered on preference assessment).
  3. Identify areas of the brain that are comprised of the brain reward circuitry (e.g., VTA area of the brain).
  4. Describe the impact of impairments of the brain reward circuitry and the implications for behavioral intervention (e.g., the difficulty with identifying stimuli that function as reinforcers).
  5. Report how behavior analysts can successfully work with the medical community when
    pharmacologic agents are prescribed for treatment or polypharmacological regimens are part of a clinical pathway.


Successful completion of webinar offers 2 (Type 2) Continuing Education Units to support the professional development of Board Certified Analyst and Board Certified Assistant Behavior Analyst.
***All sales are final.
About the Presenters

Miles G. Cunningham, Ph. D., MD

Miles G. Cunningham, Ph. D., MD, Miles G. Cunningham earned a PhD in 1993 from Massachusetts Institute of Technology, specializing in “Transplantation Strategies for the Analysis of Brain Development and Repair”. He earned an MD in 1995 from Harvard Medical School, with a special interest in neuropsychiatry and behavioral neurology. Dr. Cunningham received residency training at Massachusetts General and McLean Hospitals, while continuing neuroscience research in the laboratory of Dr. Francine Benes which focused on the study of the corticolimbic circuitry of psychopathology.

Dr. Cunningham presently administers the Laboratory of Neural Reconstruction, which studies emotional circuitry and psychopathology via precision engraftment of genetically engineered neural cells. An associate psychiatrist at McLean Hospital, he also conducts a limited private practice specializing in neuropsychiatry, psychopharmacology, psychotherapy, and cognitive and behavioral therapy. He is founder of Asniya, a philanthropic program which introduces medicine and teaches preventative care to Native American children living on underprivileged reservations.



Michael J. Cameron Ph.D., BCBA-D

Michael J. Cameron Ph.D., BCBA-D, is the Chief Scientific Officer for The Cedar Group (Eagle Rock, California). He received his doctorate in experimental psychology at Northeastern University. He was the Founding Chair of the Department of Behavior Analysis at Simmons College, an all-women’s college in Boston, Massachusetts. His research and publications are in the areas of behavior analysis, the antecedent control of aberrant behavior, behavioral medicine, and behavioral interventions





Click the purchase button below to view this material.

Successful completion of webinar offers 2 (Type 2) Continuing Education Units to support the professional development of Board Certified Analyst and Board Certified Assistant Behavior Analyst.
***All sales are final.